Skip to main content
LFST
NASDAQ Industrial Applications And Services

LifeStance Crushes Q2: Revenue Up 26%, Swings to Profit, Raises Guidance, and Authorizes $100M Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$10.62
Mkt Cap
$4.022B
52W Low
$3.805
52W High
$11.76
52W Position info
179% above low
Off High info
9.7% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LFST has more than doubled off its 52-week low of $3.805.

Summary

LifeStance Health reported Q2 2026 revenue of $435.4M (up 26% YoY), net income of $23.6M (vs. a $3.8M loss last year), and raised full-year guidance. The board also authorized a new $100M share buyback.


Key Events · Earnings and Guidance · LFST

  • Q2 Revenue Surges 26%

    Revenue hit $435.4M, driven by 19% visit growth and higher revenue per visit. Clinician base expanded 11% to 8,542.

  • Swings to Profitability

    Net income was $23.6M, a dramatic improvement from a $3.8M loss in Q2 2025. Adjusted EBITDA jumped 94% to $66.0M (15.2% margin).

  • Full-Year Guidance Raised

    2026 revenue outlook lifted to $1.685B-$1.725B, Center Margin to $570M-$594M, and Adjusted EBITDA to $215M-$235M.

  • New $100M Share Buyback Authorized

    Board approved a new $100M repurchase program, replacing the prior $100M program. The company repurchased $97.6M of stock in H1 2026.


Analysis · LFST · Industrial Applications And Services

A standout quarter saw LifeStance swing from a year-ago loss to a $23.6M profit on 26% revenue growth. The company raised full-year guidance across all key metrics and authorized a new $100M share repurchase program, signaling confidence in its cash generation and growth trajectory. This combination of strong execution and shareholder-friendly capital allocation is a clear positive signal, especially against a backdrop of heavy insider selling earlier this year.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LFST was trading at $10.62 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4B. The 52-week trading range was $3.81 to $11.76. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LFST - Latest Insights

LFST
Nov 09, 2026, 9:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $13.20
Real-time Price: $14.65 info
Change: +$1.45 (+11%) info
Market Cap: $5.536B info
LFST
Nov 09, 2026, 7:24 AM EST
Filing Type: 424B7
Importance Score:
7
Price at Filing: $12.99
Real-time Price: $14.65 info
Change: +$1.66 (+13%) info
Market Cap: $5.536B info
LFST
Nov 05, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.43
Real-time Price: $14.65 info
Change: +$1.22 (+9%) info
Market Cap: $5.536B info
LFST
Nov 05, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.50
Real-time Price: $14.65 info
Change: +$1.15 (+9%) info
Market Cap: $5.536B info
LFST
Nov 04, 2026, 7:56 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.98
Real-time Price: $14.65 info
Change: -$0.330 (-2%) info
Market Cap: $5.536B info